Search research articles
Contact Us
Filters
Showing results (171-180 of 302) with videos related to
Page
of 31
Sort By:
Oncology
|
April 15, 2010
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas
Shelly S Lo, Alok A Khorana, Milind Javle, et al.
Investigational New Drugs
|
August 25, 2011
A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy
Ramesh K Ramanathan, Joe J Stephenson, Glen J Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2005
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H Oettle, D Richards, R K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2009
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies
William C Zamboni, Suresh Ramalingam, David M Friedland, et al.
ESMO Open
|
August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort
Howard A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Annals of Surgical Oncology
|
November 25, 2010
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer
Philip Q Bao, Ramesh K Ramanathan, Alyssa Krasinkas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)
Gregory N Dietsch, Tressa D Randall, Raphael Gottardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial
Patrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2014
A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma
Donald W Northfelt, Ramesh K Ramanathan, Peter A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors
Ramesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 302) with videos related to
Sort By:
Page
of 31
Oncology
|
April 15, 2010
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas
Shelly S Lo, Alok A Khorana, Milind Javle, et al.
Investigational New Drugs
|
August 25, 2011
A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy
Ramesh K Ramanathan, Joe J Stephenson, Glen J Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2005
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H Oettle, D Richards, R K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2009
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies
William C Zamboni, Suresh Ramalingam, David M Friedland, et al.
ESMO Open
|
August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort
Howard A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Annals of Surgical Oncology
|
November 25, 2010
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer
Philip Q Bao, Ramesh K Ramanathan, Alyssa Krasinkas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)
Gregory N Dietsch, Tressa D Randall, Raphael Gottardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial
Patrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2014
A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma
Donald W Northfelt, Ramesh K Ramanathan, Peter A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors
Ramesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Page
of 31